Login / Signup

Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi-institutional retrospective study.

Takehiro NodaHidekazu TakahashiMitsuyoshi TeiNaohiro NishidaTaishi HataYutaka TakedaMasayuki OhueHiroshi WadaTsunekazu MizushimaTadafumi AsaokaMamoru UemuraShogo KobayashiKohei MurataTaroh SatohYuichiro DokiHidetoshi Eguchinull null
Published in: Annals of gastroenterological surgery (2022)
Neoadjuvant chemotherapy for resectable CRLM might prolong the recurrence-free survival period for intermediate-risk patients with preoperative risk scores in the range of 1-10, but the overall survival was not improved by neoadjuvant chemotherapy.
Keyphrases
  • neoadjuvant chemotherapy
  • free survival
  • locally advanced
  • rectal cancer
  • lymph node
  • sentinel lymph node
  • squamous cell carcinoma
  • radiation therapy
  • patients undergoing
  • liver metastases